Biomedical Catalyst funding competition

Main Content

What's involved?

Primer award

The aim of this award is to test a well-developed concept and show its effectiveness in a relevant environment through:

  • Experimental evaluation (lab-scale)
  • Initial demonstration using in vitro and in vivo models (not human clinical trials)
  • Exploring potential production mechanisms
  • Early-stage prototyping
  • Product development planning
  • Intellectual property protection

Projects are expected to range in size from total costs of £200,000 to £1.5 million. Projects should last up to 2 years. Projects must start by 1 August 2017 and end by 1 August 2019.

Feasibility award

The aim of the feasibility award is to explore and test the commercial potential of early-stage ideas through:

  • Reviewing research evidence and identifying possible applications
  • Assessing business opportunities
  • Investigating intellectual property issues
  • Validating initial concepts or existing pre-clinical work through experimental studies
  • Identifying areas for further development

Total project costs expected to be up to £200,000. Projects should last between 3 months and 1 year. Projects must start by 1 August 2017 and end by 1 August 2018.

For both awards, you could get up to:

  • 70% of your eligible project costs if you are a small or micro business
  • 60% if you are a medium-sized business

Contact us for more details

<h2>Related articles</h2>